257 related articles for article (PubMed ID: 2526742)
21. Depressed interleukin-12-producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients.
Spolarics Z; Siddiqi M; Siegel JH; Garcia ZC; Stein DS; Denny T; Deitch EA
Crit Care Med; 2003 Jun; 31(6):1722-9. PubMed ID: 12794411
[TBL] [Abstract][Full Text] [Related]
22. Decreased interleukin-10 production by neonatal monocytes and T cells: relationship to decreased production and expression of tumor necrosis factor-alpha and its receptors.
Chheda S; Palkowetz KH; Garofalo R; Rassin DK; Goldman AS
Pediatr Res; 1996 Sep; 40(3):475-83. PubMed ID: 8865287
[TBL] [Abstract][Full Text] [Related]
23. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-alpha by lipopolysaccharide-stimulated human monocytes.
Couturier C; Jahns G; Kazatchkine MD; Haeffner-Cavaillon N
Eur J Immunol; 1992 Jun; 22(6):1461-6. PubMed ID: 1376258
[TBL] [Abstract][Full Text] [Related]
24. T cell activation signals up-regulate p38 mitogen-activated protein kinase activity and induce TNF-alpha production in a manner distinct from LPS activation of monocytes.
Schafer PH; Wang L; Wadsworth SA; Davis JE; Siekierka JJ
J Immunol; 1999 Jan; 162(2):659-68. PubMed ID: 9916683
[TBL] [Abstract][Full Text] [Related]
25. Growth-promoting activity of IL-1 alpha, IL-6, and tumor necrosis factor-alpha in combination with IL-2, IL-4, or IL-7 on murine thymocytes. Differential effects on CD4/CD8 subsets and on CD3+/CD3- double-negative thymocytes.
Suda T; Murray R; Guidos C; Zlotnik A
J Immunol; 1990 Apr; 144(8):3039-45. PubMed ID: 1969882
[TBL] [Abstract][Full Text] [Related]
26. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
27. Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.
Yang SC; Owen-Schaub LB; Roth JA; Grimm EA
Cancer Res; 1990 Jun; 50(12):3526-32. PubMed ID: 2160321
[TBL] [Abstract][Full Text] [Related]
28. Human retinal pigment epithelial cell interleukin-8 and monocyte chemotactic protein-1 modulation by T-lymphocyte products.
Elner SG; Elner VM; Bian ZM; Lukacs NW; Kurtz RM; Strieter RM; Kunkel SL
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):446-55. PubMed ID: 9040478
[TBL] [Abstract][Full Text] [Related]
29. Human T cells and interleukin 4 inhibit the release of interleukin 1 induced by lipopolysaccharide in serum-free cultures of autologous monocytes.
Weiss L; Haeffner-Cavaillon N; Laude M; Cavaillon JM; Kazatchkine MD
Eur J Immunol; 1989 Jul; 19(7):1347-50. PubMed ID: 2668014
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
Tohma S; Lipsky PE
J Immunol; 1991 Apr; 146(8):2544-52. PubMed ID: 1707911
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of IL-12 (cytotoxic lymphocyte maturation factor)-, IL-2-, and IL-7-induced effects on immunomagnetically purified CD56+ NK cells.
Naume B; Gately M; Espevik T
J Immunol; 1992 Apr; 148(8):2429-36. PubMed ID: 1373169
[TBL] [Abstract][Full Text] [Related]
32. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
[TBL] [Abstract][Full Text] [Related]
33. Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis.
Wanidworanun C; Strober W
J Immunol; 1993 Dec; 151(12):6853-61. PubMed ID: 8258695
[TBL] [Abstract][Full Text] [Related]
34. A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.
Chernoff AE; Granowitz EV; Shapiro L; Vannier E; Lonnemann G; Angel JB; Kennedy JS; Rabson AR; Wolff SM; Dinarello CA
J Immunol; 1995 May; 154(10):5492-9. PubMed ID: 7730651
[TBL] [Abstract][Full Text] [Related]
35. Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes.
Liese AM; Siddiqi MQ; Siegel JH; Denny T; Spolarics Z
J Leukoc Biol; 2001 Aug; 70(2):289-96. PubMed ID: 11493622
[TBL] [Abstract][Full Text] [Related]
36. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.
Aderka D; Le JM; Vilcek J
J Immunol; 1989 Dec; 143(11):3517-23. PubMed ID: 2584704
[TBL] [Abstract][Full Text] [Related]
37. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
38. On the role of monokines in the generation of nonspecific suppressor T cell activity in vitro.
Baxevanis CN; Dedousis GV; Gritzapis AD; Papadopoulos NG; Arsenis P; Katsiyiannis A; Papamichail M
Immunopharmacol Immunotoxicol; 1994 May; 16(2):225-45. PubMed ID: 8077608
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-12 activates human gamma delta T cells: synergistic effect of tumor necrosis factor-alpha.
Ueta C; Kawasumi H; Fujiwara H; Miyagawa T; Kida H; Ohmoto Y; Kishimoto S; Tsuyuguchi I
Eur J Immunol; 1996 Dec; 26(12):3066-73. PubMed ID: 8977306
[TBL] [Abstract][Full Text] [Related]
40. Cytokine production by human fetal microglia and astrocytes. Differential induction by lipopolysaccharide and IL-1 beta.
Lee SC; Liu W; Dickson DW; Brosnan CF; Berman JW
J Immunol; 1993 Apr; 150(7):2659-67. PubMed ID: 8454848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
